The large cross-sectional study highlights a significant link between elevated inflammatory indices and MAFLD in hypertensive ...
Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced financial results for its fiscal 2025 first quarter ended December 31, 2024. The Company is hosting ...